In the BioHarmony Drug Report Database
Tomivosertib
Tomivosertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against MAP kinase-interacting serine/threonine-protein kinase 2 and MAP kinase-interacting serine/threonine-protein kinase 1. In addition, it is known to target serine/threonine-protein kinase 17A and dual specificity protein kinase CLK4.
Trade Name
|
|
|---|---|
Common Name
|
tomivosertib |
ChEMBL ID
|
CHEMBL4073443 |
Indication
|
|
Drug Class
|
Serine/threonine kinase inhibitors |
Image (chem structure or protein)